home / stock / nviv / nviv quote
$8.11 Last:
94.95% Change Percent:
$7.74 Open:
$4.16 Previous Close:
$8.2 High:
$7.51 Low:
75,386 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2022-08-12 | 7.74 | 4.16 | 8.2 | 7.51 | 75,386 |
2022-08-11 | 7.51 | 4.16 | 7.91 | 7.3 | 96,135 |
2022-08-10 | 8.37 | 4.16 | 8.37 | 7.04 | 128,549 |
2022-08-09 | 7.97 | 4.16 | 8.67 | 7.8322 | 210,942 |
2022-08-08 | 8.1 | 4.16 | 8.7499 | 7.41 | 372,793 |
2022-08-05 | 7.3 | 4.16 | 9.89 | 6.91 | 3,676,677 |
2022-08-04 | 7.53 | 4.16 | 13.7699 | 6.85 | 38,242,832 |
2022-08-03 | 3.95 | 4.16 | 4.62 | 3.95 | 74,080 |
2022-08-02 | 3.85 | 4.16 | 3.93 | 3.75 | 19,681 |
2022-08-01 | 4.01 | 4.16 | 4.1399 | 3.91 | 27,565 |
2022-07-29 | 4.01 | 4.16 | 4.19 | 3.75 | 25,382 |
2022-07-28 | 4.16 | 4.16 | 4.16 | 3.87 | 2,688 |
2022-07-26 | 3.96 | 3.96 | 4.01 | 3.875 | 6,324 |
2022-07-19 | 3.98 | 4.01 | 4.01 | 3.7949 | 10,143 |
2022-07-18 | 3.97 | 3.81 | 4.1504 | 3.81 | 19,389 |
2022-07-15 | 3.9816 | 3.89 | 3.9999 | 3.89 | 1,718 |
2022-07-14 | 3.898 | 4.03 | 4.045 | 3.898 | 1,352 |
2022-07-13 | 3.7952 | 4.085 | 4.17 | 3.78 | 26,099 |
2022-07-12 | 3.735 | 3.7801 | 3.9599 | 3.653 | 21,354 |
2022-07-11 | 3.79 | 3.75 | 4.1403 | 3.75 | 8,964 |
InVivo Therapeutics Holdings Corp. Company Name:
NVIV Stock Symbol:
NASDAQ Market:
News, Short Squeeze, Breakout and More Instantly...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock InVivo Therapeutics (NASDAQ: NVIV ) stock is rocketing higher on Thursday despite a lack of news concerning the clinical-stage biomaterials and biotechnology company. So what has NVIV stoc...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com It’s time for another dive into the biggest pre-market stock movers as we see what’s affecting shares on Thursday! Penny stocks rule the markets this morning as trader...
Manuscript details patient outcomes through 24-month follow up visit InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced the publication of a peer-reviewed manuscript in Neurosurgery describing the previously disclosed 12- and 24-month data from the Company...